— Know what they know.
Not Investment Advice

ABAX NASDAQ

Abaxis, Inc.
1W: +0.0% 1M: -0.3% 3M: +19.1% 1Y: +81.1% 3Y: +75.7% 5Y: +113.7%
$83.00
Last traded 2018-08-09 — delisted
NASDAQ · Healthcare · Medical - Equipment & Services

Balance Sheet Trends

Total Assets
$341M +11.6% ▲
5Y CAGR: +11.1%
Total Liabilities
$50M +27.9% ▲
5Y CAGR: +14.5%
Shareholders Equity
$291M +9.2% ▲
5Y CAGR: +10.5%
Cash & Investments
$167M +16.7% ▲
5Y CAGR: +16.3%
Total Debt
$177K -36.3% ▼
5Y CAGR: -23.6%
Net Debt
-$46M +49.4% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2013FY2014FY2015FY2016FY2017
— Assets —
Cash$74M$107M$88M$91M$46M
Short-Term Investments$29M$26M$41M$52M$121M
Cash & ST Investments$103M$133M$130M$143M$167M
Net Receivables$29M$35M$41M$48M$48M
Inventory$27M$36M$35M$39M$44M
Other Current Assets$9M$6M$6M$42K$5M
Total Current Assets$165M$210M$212M$233M$264M
Property, Plant & Equip.$27M$27M$27M$34M$35M
Goodwill & Intangibles$2M$1M$1M$1M$1M
Long-Term Investments$21M$27M$25M$25M$23M
Other Non-Current Assets$74K$119K$2M$8M$9M
Total Non-Current Assets$52M$59M$59M$72M$77M
Total Assets$217M$269M$271M$306M$341M
— Liabilities —
Accounts Payable$7M$7M$8M$12M$12M
Short-Term Debt$0$0$0$0$29M
Deferred Revenue$1M$1M$2M$1M$816K
Other Current Liabilities-$6M$22M$7M-$8M$2M
Total Current Liabilities$17M$41M$29M$33M$44M
Long-Term Debt$480K$379K$278K$177K$177K
Other Non-Current Liab.$922K$4M$3M$4M$5M
Total Non-Current Liabilities$6M$8M$6M$6M$7M
Total Liabilities$23M$49M$35M$39M$50M
— Equity —
Common Stock$125M$0$0$0$147M
Retained Earnings$69M$88M$109M$130M$144M
Accumulated OCI-$5K-$8K-$7K-$12K-$177K
Total Stockholders Equity$194M$220M$236M$266M$291M
Total Liabilities & Equity$217M$269M$271M$306M$341M
— Key Metrics —
Total Debt$581K$480K$379K$278K$177K
Net Debt-$73M-$107M-$88M-$91M-$46M
Total Investments$50M$53M$67M$77M$144M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms